Haixiang Zhang

Title: Haixiang Zhang: Innovator in Peptide Synthesis

Introduction

Haixiang Zhang is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of peptide synthesis, particularly through his innovative methods for manufacturing pharmaceuticals.

Latest Patents

Zhang holds a patent for a method for the manufacture of degarelix. This patent describes a step-wise synthesis of degarelix that includes 0.3% by weight or less of 4-([2-(5-hydantoyl)]acetylamino)-phenylalanine analog on a solid support. The process involves providing a solution of an amino acid or peptide with a protected α-amino group, contacting the support with the solution in the presence of a reagent for forming a peptide bond, and removing the protecting group using an organic base. The method results in degarelix of high purity, showcasing Zhang's expertise in the field.

Career Highlights

Zhang is currently employed at Polypeptide Laboratories A/S, where he continues to advance his research in peptide synthesis. His work has been instrumental in developing high-purity pharmaceutical compounds, which are crucial for effective medical treatments.

Collaborations

Zhang has collaborated with notable colleagues, including Jens Fomsgaard and Gunnar Staerkaer. These partnerships have contributed to the success of his research and the advancement of peptide synthesis techniques.

Conclusion

Haixiang Zhang is a prominent figure in the field of peptide synthesis, with a focus on innovative methods for pharmaceutical manufacturing. His contributions, particularly in the synthesis of degarelix, highlight his expertise and commitment to advancing medical science.